The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France-Reference-Cited by-同舟云学术

The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France

Published:1999-01 Issue:2 Volume:17 Page:142-151
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Coudeville Laurent,Paree François,Lebrun Thérèse,Sailly Jean-claude

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Live vaccine used to prevent the spread of varicella in children in hospital;Takahashi;Lancet,1974

2. Weller TH. Varicella-Herpes Zoster Virus in Viral Infections of Humans. Epidemiology and Control, 3rd edn, Ch. 25. Plenum Medical Book Company, New York, 1991

3. Flahaut A, Dreau H, Farran N et al. Epidémiologie des maladies transmissibles en médecine libérale: bilan du réseau sentinelles en 1996. BEH, 1997, 33

4. The epidemiology of varicella and its complications;Choo;Journal of Infectious Diseases,1995

5. Community impact of childhood varicella infections;Yawn;Journal of Pediatrics,1997

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing affordability and profit in a non-cooperative, coordinated, hypothetical pediatric vaccine market via sequential optimization;Health Care Management Science;2024-06-29

2. The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020–2070);Scientific Reports;2024-05-24

3. Systematic review of economic evaluations of varicella vaccination programmes;PLOS ONE;2023-03-27

4. Varicella Vaccines;Plotkin's Vaccines;2023

5. Economic burden of varicella in Europe in the absence of universal varicella vaccination;BMC Public Health;2021-12